117 related articles for article (PubMed ID: 29860423)
21. Loss of striatal 90-kDa ribosomal S6 kinase (Rsk) is a key factor for motor, synaptic and transcription dysfunction in Huntington's disease.
Anglada-Huguet M; Giralt A; Rué L; Alberch J; Xifró X
Biochim Biophys Acta; 2016 Jul; 1862(7):1255-66. PubMed ID: 27063456
[TBL] [Abstract][Full Text] [Related]
22. The mGluR5 positive allosteric modulator, CDPPB, ameliorates pathology and phenotypic signs of a mouse model of Huntington's disease.
Doria JG; de Souza JM; Andrade JN; Rodrigues HA; Guimaraes IM; Carvalho TG; Guatimosim C; Dobransky T; Ribeiro FM
Neurobiol Dis; 2015 Jan; 73():163-73. PubMed ID: 25160573
[TBL] [Abstract][Full Text] [Related]
23. A small molecule p75NTR ligand normalizes signalling and reduces Huntington's disease phenotypes in R6/2 and BACHD mice.
Simmons DA; Belichenko NP; Ford EC; Semaan S; Monbureau M; Aiyaswamy S; Holman CM; Condon C; Shamloo M; Massa SM; Longo FM
Hum Mol Genet; 2016 Nov; 25(22):4920-4938. PubMed ID: 28171570
[TBL] [Abstract][Full Text] [Related]
24. Increased Olfactory Bulb BDNF Expression Does Not Rescue Deficits in Olfactory Neurogenesis in the Huntington's Disease R6/2 Mouse.
Smail S; Bahga D; McDole B; Guthrie K
Chem Senses; 2016 Mar; 41(3):221-32. PubMed ID: 26783111
[TBL] [Abstract][Full Text] [Related]
25. Small-molecule TrkB receptor agonists improve motor function and extend survival in a mouse model of Huntington's disease.
Jiang M; Peng Q; Liu X; Jin J; Hou Z; Zhang J; Mori S; Ross CA; Ye K; Duan W
Hum Mol Genet; 2013 Jun; 22(12):2462-70. PubMed ID: 23446639
[TBL] [Abstract][Full Text] [Related]
26. Stimulation of S1PR5 with A-971432, a selective agonist, preserves blood-brain barrier integrity and exerts therapeutic effect in an animal model of Huntington's disease.
Di Pardo A; Castaldo S; Amico E; Pepe G; Marracino F; Capocci L; Giovannelli A; Madonna M; van Bergeijk J; Buttari F; van der Kam E; Maglione V
Hum Mol Genet; 2018 Jul; 27(14):2490-2501. PubMed ID: 29688337
[TBL] [Abstract][Full Text] [Related]
27. BDNF and TRiC-inspired reagent rescue cortical synaptic deficits in a mouse model of Huntington's disease.
Gu Y; Pope A; Smith C; Carmona C; Johnstone A; Shi L; Chen X; Santos S; Bacon-Brenes CC; Shoff T; Kleczko KM; Frydman J; Thompson LM; Mobley WC; Wu C
Neurobiol Dis; 2024 Jun; 195():106502. PubMed ID: 38608784
[TBL] [Abstract][Full Text] [Related]
28. Selective reduction of striatal mature BDNF without induction of proBDNF in the zQ175 mouse model of Huntington's disease.
Ma Q; Yang J; Li T; Milner TA; Hempstead BL
Neurobiol Dis; 2015 Oct; 82():466-477. PubMed ID: 26282324
[TBL] [Abstract][Full Text] [Related]
29. Intravenous immunoglobulin ameliorates motor and cognitive deficits and neuropathology in R6/2 mouse model of Huntington's disease by decreasing mutant huntingtin protein level and normalizing NF-κB signaling pathway.
Liu SY; Yu XL; Zhu J; Liu XM; Zhang Y; Dong QX; Ma S; Liu RT
Brain Res; 2018 Oct; 1697():21-33. PubMed ID: 29902468
[TBL] [Abstract][Full Text] [Related]
30. Effects of chronic stress on the onset and progression of Huntington's disease in transgenic mice.
Mo C; Renoir T; Hannan AJ
Neurobiol Dis; 2014 Nov; 71():81-94. PubMed ID: 25088714
[TBL] [Abstract][Full Text] [Related]
31. Brain-derived neurotrophic factor restores synaptic plasticity in a knock-in mouse model of Huntington's disease.
Lynch G; Kramar EA; Rex CS; Jia Y; Chappas D; Gall CM; Simmons DA
J Neurosci; 2007 Apr; 27(16):4424-34. PubMed ID: 17442827
[TBL] [Abstract][Full Text] [Related]
32. Reduced Expression of Foxp1 as a Contributing Factor in Huntington's Disease.
Louis Sam Titus ASC; Yusuff T; Cassar M; Thomas E; Kretzschmar D; D'Mello SR
J Neurosci; 2017 Jul; 37(27):6575-6587. PubMed ID: 28550168
[TBL] [Abstract][Full Text] [Related]
33. BH3-only proteins Bid and Bim(EL) are differentially involved in neuronal dysfunction in mouse models of Huntington's disease.
García-Martínez JM; Pérez-Navarro E; Xifró X; Canals JM; Díaz-Hernández M; Trioulier Y; Brouillet E; Lucas JJ; Alberch J
J Neurosci Res; 2007 Sep; 85(12):2756-69. PubMed ID: 17387706
[TBL] [Abstract][Full Text] [Related]
34. Blood level of brain-derived neurotrophic factor mRNA is progressively reduced in rodent models of Huntington's disease: restoration by the neuroprotective compound CEP-1347.
Conforti P; Ramos C; Apostol BL; Simmons DA; Nguyen HP; Riess O; Thompson LM; Zuccato C; Cattaneo E
Mol Cell Neurosci; 2008 Sep; 39(1):1-7. PubMed ID: 18571429
[TBL] [Abstract][Full Text] [Related]
35. Overexpression of BDNF and Full-Length TrkB Receptor Ameliorate Striatal Neural Survival in Huntington's Disease.
Silva A; Naia L; Dominguez A; Ribeiro M; Rodrigues J; Vieira OV; Lessmann V; Rego AC
Neurodegener Dis; 2015; 15(4):207-18. PubMed ID: 25896770
[TBL] [Abstract][Full Text] [Related]
36. Role of Phosphodiesterases in Huntington's Disease.
Fusco FR; Paldino E
Adv Neurobiol; 2017; 17():285-304. PubMed ID: 28956337
[TBL] [Abstract][Full Text] [Related]
37. Trehalose rescues glial cell dysfunction in striatal cultures from HD R6/1 mice at early postnatal development.
Perucho J; Gómez A; Muñoz MP; de Yébenes JG; Mena MÁ; Casarejos MJ
Mol Cell Neurosci; 2016 Jul; 74():128-45. PubMed ID: 27236019
[TBL] [Abstract][Full Text] [Related]
38. Electroconvulsive shock ameliorates disease processes and extends survival in huntingtin mutant mice.
Mughal MR; Baharani A; Chigurupati S; Son TG; Chen E; Yang P; Okun E; Arumugam T; Chan SL; Mattson MP
Hum Mol Genet; 2011 Feb; 20(4):659-69. PubMed ID: 21106706
[TBL] [Abstract][Full Text] [Related]
39. 7,8-dihydroxyflavone ameliorates cognitive and motor deficits in a Huntington's disease mouse model through specific activation of the PLCγ1 pathway.
García-Díaz Barriga G; Giralt A; Anglada-Huguet M; Gaja-Capdevila N; Orlandi JG; Soriano J; Canals JM; Alberch J
Hum Mol Genet; 2017 Aug; 26(16):3144-3160. PubMed ID: 28541476
[TBL] [Abstract][Full Text] [Related]
40. Progressive loss of BDNF in a mouse model of Huntington's disease and rescue by BDNF delivery.
Zuccato C; Liber D; Ramos C; Tarditi A; Rigamonti D; Tartari M; Valenza M; Cattaneo E
Pharmacol Res; 2005 Aug; 52(2):133-9. PubMed ID: 15967378
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
